SG11202009028WA - Traditional Chinese Medicinal Composition for Preventing and/or Treating Ischemic Reperfusion Injury - Google Patents
Traditional Chinese Medicinal Composition for Preventing and/or Treating Ischemic Reperfusion InjuryInfo
- Publication number
- SG11202009028WA SG11202009028WA SG11202009028WA SG11202009028WA SG11202009028WA SG 11202009028W A SG11202009028W A SG 11202009028WA SG 11202009028W A SG11202009028W A SG 11202009028WA SG 11202009028W A SG11202009028W A SG 11202009028WA SG 11202009028W A SG11202009028W A SG 11202009028WA
- Authority
- SG
- Singapore
- Prior art keywords
- preventing
- traditional chinese
- chinese medicinal
- reperfusion injury
- medicinal composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810299213 | 2018-04-04 | ||
| PCT/CN2019/079420 WO2019192339A1 (en) | 2018-04-04 | 2019-03-25 | Traditional chinese medicine composition for preventing and/or treating ischemic reperfusion injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202009028WA true SG11202009028WA (en) | 2020-10-29 |
Family
ID=68099988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202009028WA SG11202009028WA (en) | 2018-04-04 | 2019-03-25 | Traditional Chinese Medicinal Composition for Preventing and/or Treating Ischemic Reperfusion Injury |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210038668A1 (en) |
| EP (1) | EP3777871A4 (en) |
| JP (1) | JP7148629B2 (en) |
| KR (1) | KR20200140277A (en) |
| CN (1) | CN110339232A (en) |
| CA (1) | CA3093031A1 (en) |
| RU (1) | RU2020134524A (en) |
| SG (1) | SG11202009028WA (en) |
| TW (1) | TW201944990A (en) |
| WO (1) | WO2019192339A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111686103A (en) * | 2019-03-11 | 2020-09-22 | 中国科学院上海药物研究所 | Protection effect and application of magnesium salvianolate or pharmaceutical composition containing magnesium salvianolate on liver ischemia reperfusion |
| CN111888349B (en) * | 2020-07-29 | 2021-10-22 | 温州医科大学附属第二医院、温州医科大学附属育英儿童医院 | Action of nimbin in preparing medicine for promoting survival of ischemic superlong random skin flap |
| CN114642401A (en) * | 2020-12-18 | 2022-06-21 | 中国科学院深圳先进技术研究院 | System and method for in vivo observation of capillary blood vessels in animal bone |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100404035C (en) * | 2003-09-23 | 2008-07-23 | 天津天士力制药股份有限公司 | Combination of Chinese traditional medicine for curing cardiovascular diseases and cerebrovascular disease |
| CN100339085C (en) | 2003-09-23 | 2007-09-26 | 天津天士力制药股份有限公司 | Combination of Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases |
| CN1686462A (en) * | 2005-05-13 | 2005-10-26 | 张海峰 | Compound xuesaitong injection and its preparation method |
| CN1919252B (en) * | 2005-08-24 | 2011-09-21 | 天津天士力制药股份有限公司 | Medicine for treating cardiovascular and cerebrovascular disease |
| CN1857388A (en) * | 2006-03-17 | 2006-11-08 | 崔彬 | Preparation and application of notoginseng stem and leaf total saponin composition |
| CN101450106A (en) * | 2008-12-25 | 2009-06-10 | 浙江大学 | Traditional Chinese medicine composition with ischemic myocardium angiogenesis promoting function |
| CN102526423A (en) * | 2012-01-06 | 2012-07-04 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | Medicine composition for treating ischemic heart disease |
| CN103385920A (en) * | 2012-05-07 | 2013-11-13 | 天士力制药集团股份有限公司 | Novel application of qi-tonifying dropping pill containing Radix astragali and root of red-rooted salvia |
| CN104435105B (en) * | 2013-09-25 | 2019-05-17 | 天士力医药集团股份有限公司 | One kind is by Radix Astragali, Radix Salviae Miltiorrhizae, Radix Notoginseng, the pharmaceutical composition of dalbergia wood preparation |
| WO2015046574A1 (en) | 2013-09-30 | 2015-04-02 | 国立大学法人新潟大学 | Drug to prevent bleeding caused by reperfusion following ischemia |
| CN104107424B (en) * | 2014-07-31 | 2015-07-15 | 杜志政 | Qi cultivating thrombolytic medicinal composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| CN105796743A (en) * | 2014-12-31 | 2016-07-27 | 广东广发制药有限公司 | Compound thrombus relieving soft capsule and preparation technology thereof |
| CN108464988A (en) * | 2018-06-21 | 2018-08-31 | 湖南中医药大学 | Prevent and treat cerebral ischemia re-pouring injured pharmaceutical composition and application method |
-
2019
- 2019-03-12 TW TW108108267A patent/TW201944990A/en unknown
- 2019-03-25 KR KR1020207028942A patent/KR20200140277A/en not_active Application Discontinuation
- 2019-03-25 CA CA3093031A patent/CA3093031A1/en active Pending
- 2019-03-25 US US17/041,795 patent/US20210038668A1/en not_active Abandoned
- 2019-03-25 EP EP19781599.6A patent/EP3777871A4/en not_active Withdrawn
- 2019-03-25 SG SG11202009028WA patent/SG11202009028WA/en unknown
- 2019-03-25 JP JP2020554106A patent/JP7148629B2/en active Active
- 2019-03-25 WO PCT/CN2019/079420 patent/WO2019192339A1/en active Application Filing
- 2019-03-25 RU RU2020134524A patent/RU2020134524A/en unknown
- 2019-03-26 CN CN201910233706.5A patent/CN110339232A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019192339A1 (en) | 2019-10-10 |
| KR20200140277A (en) | 2020-12-15 |
| EP3777871A1 (en) | 2021-02-17 |
| RU2020134524A (en) | 2022-05-05 |
| EP3777871A4 (en) | 2022-03-23 |
| CN110339232A (en) | 2019-10-18 |
| US20210038668A1 (en) | 2021-02-11 |
| CA3093031A1 (en) | 2019-10-10 |
| TW201944990A (en) | 2019-12-01 |
| JP2021520358A (en) | 2021-08-19 |
| JP7148629B2 (en) | 2022-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202009028WA (en) | Traditional Chinese Medicinal Composition for Preventing and/or Treating Ischemic Reperfusion Injury | |
| PL3468532T3 (en) | Dispensing device and pharmaceutical composition for the treatment of rhinitis | |
| IL266623A (en) | Pharmaceutical composition for use in the therapeutic treatment of cancer and complications of cancer | |
| EP3858353A4 (en) | Pharmaceutical composition for preventing and treating nitm and pharmaceutical use thereof | |
| IL267159B (en) | Pharmaceutical composition comprising e7386 in combination with lenvatinib for treating tumors | |
| PL3362449T3 (en) | Sibiriline derivatives for use for preventing and/or treating disorders associated with cellular necroptosis | |
| HK1257585A1 (en) | Medicine for preventing and treating skin fibrosis and use of the medicine | |
| EP3708173C0 (en) | Pharmaceutical composition comprising mirna-3140 for use in treating cancer | |
| HK1255835A1 (en) | Therapeutic compositions and methods for treating hepatitis b | |
| ZA202000884B (en) | Compositions for treating skin and mucous membrane infections | |
| PT3290051T (en) | Pharmaceutical composition for treating and/or preventing cancer | |
| PL3810128T3 (en) | Compositions for treating and/or preventing protein-aggregation diseases | |
| HK1257590A1 (en) | Medicine for preventing and treating medicinal kidney injury and the use of the medicine | |
| EP3609578A4 (en) | Pharmaceutical combination and its use for treating synucleinopathies | |
| PT3236961T (en) | Pharmaceutical composition for preventing or treating cancer and method using thereof | |
| IL261182B (en) | Leptin antagonist for use in the treatment of ischemia and reperfusion injury | |
| EP3552632A4 (en) | Medicinal composition for treating and preventing chronic disease | |
| HK1248573A1 (en) | Vvyp used for preventing and/or treating liver injuries | |
| IL281404A (en) | Traditional chinese medicine composition for treating metabolic syndrome and preparations thereof | |
| HK1255631A1 (en) | Pharmaceutical composition for preventing and treating sleep disorders | |
| IL280569A (en) | Uvb-induced photodamages: compositions and methods for topical treatment | |
| EP3648768C0 (en) | Imeglimin for preventing and/or treating hepatocellular carcinoma | |
| AU2018903405A0 (en) | Methods and products for preventing and/or treating reperfusion injury | |
| EP4085908A4 (en) | Pharmaceutical combination for treating tumors and application thereof | |
| AU2017903647A0 (en) | Methods and products for preventing and/or treating reperfusion injury |